| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679877 | Alzheimer's & Dementia | 2018 | 11 Pages |
Abstract
Combining CSF biomarkers representing AD and Lewy body pathologies may have clinical value in the differential diagnosis of AD.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Min Shi, Lu Tang, Jon B. Toledo, Carmen Ginghina, Hua Wang, Patrick Aro, Poul H. Jensen, Daniel Weintraub, Alice S. Chen-Plotkin, David J. Irwin, Murray Grossman, Leo McCluskey, Lauren B. Elman, David A. Wolk, Edward B. Lee, Leslie M. Shaw,